Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Puretech Health Plc ADR
(NQ:
PRTC
)
27.64
-1.15 (-3.99%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puretech Health Plc ADR
< Previous
1
2
3
4
5
6
7
Next >
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
November 11, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
November 09, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Participation at the Jefferies London Healthcare Conference
November 09, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
November 01, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary
October 14, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
October 05, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being
October 05, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan
September 29, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance
September 20, 2021
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 14, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
September 10, 2021
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
August 30, 2021
Gainers Valneva (NASDAQ:VALN) stock moved upwards by 29.61% to $49.9 during Monday's regular session. Valneva's stock is trading at a volume of 143.0K shares as of...
Via
Benzinga
Earnings Scheduled For August 24, 2021
August 24, 2021
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter. • Genetron Holdings (NASDAQ:GTH) is...
Via
Benzinga
PureTech Health plc – Half-Year Report
August 24, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021
August 23, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
August 17, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
August 13, 2021
From
PureTech Health plc
Via
Business Wire
Imbrium Therapeutics To Develop PureTech's Non-Opioid Candidate For Chronic Bladder Condition
August 11, 2021
Imbrium Therapeutics has exercised a license option to develop PureTech Health plc's (NASDAQ: PRTC) LYT-503/IMB-150 (formerly designated as ALV-107...
Via
Benzinga
PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome
August 11, 2021
From
PureTech Health plc
Via
Business Wire
PureTech: Notice of Half-Yearly Results
August 03, 2021
From
PureTech Health plc
Via
Business Wire
The Week In SPAC News - Sunday, July 25
July 25, 2021
In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled.
Via
Talk Markets
PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD
July 22, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing
July 21, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
July 19, 2021
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
July 15, 2021
Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 8.03% to $30.0 during Thursday's regular session. The current volume of 180.7K shares is 71.9% of Nkarta's...
Via
Benzinga
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
July 09, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology on Qualcomm Snapdragon Mobile Platforms
July 08, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Health To Test LYT-200 / Tislelizumab Combo In Difficult To Treat Cancer
July 07, 2021
PureTech Health plc (NASDAQ: PRTC) has announced a clinical trial and supply agreement with an affiliate of BeiGene Ltd (NASDAQ: BGNE). The partnership...
Via
Benzinga
PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors
July 07, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Disease
June 30, 2021
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.